0227/2012 - Aborto e misoprostol: usos médicos, práticas de saúde e controvérsia científica Abortion and misoprostol: health practices and scientific controversy
Este artigo coloca em perspectiva a controvérsia entre a associação do uso de misoprostol para aborto e teratogenicidade, encontrada em estudos do tipo relato de caso, e a consagração do uso de medicamentos à base do fármaco na área médico-obstétrica e em documentos normativos nacionais e internacionais que regulam o registro e a circulação de produtos farmacêuticos. Através do método monográfico, foram revisados, sistematizados e analisados documentos oficiais da ANVISA, Ministério da Saúde e Organização Mundial da Saúde sobre o uso do misoprostol, bem como 68 artigos do tipo relato de casos clínicos, publicados em periódicos científicos nacionais, que associam aborto, misoprostol e teratogenicidade. A interdição legal do aborto impede a prescrição e uso adequados de uma droga que produz efeitos eficazes e seguros como o misoprostol. Assim, o grande malefício à saúde de mulheres está ligado não a características intrínsecas ao fármaco, mas a argumentos morais que representam descaso e desrespeito aos direitos fundamentais de mulheres
Palavras-chave:
aborto
misoprostol
síndrome de Moebius
saúde pública
saúde
produção de conhecimentos
Abstract:
This article puts into perspective the controversy between the association between use of misoprostol for abortion and teratogenicity studies of the type found in a case report, and the consecration of the use of herbal medicinal drug in the medical-obstetric and national norms and international governing the registration and circulation of pharmaceuticals. Through the monographic method, were reviewed, systematized and analyzed official documents of ANVISA, Ministry of Health and World Health Organization on the use of misoprostol, as well as 68 articles such as case reports, published in national journals, linking abortion , misoprostol and teratogenicity. The legal prohibition of abortion prevents the proper prescription and use of a drug that produces effects safe and effective as misoprostol. Thus, the great harm to the health of women is linked not to the intrinsic characteristics of the drug, but the moral arguments that represent negligence and contempt for the fundamental rights of women.
Keywords:
abortion
misoprostol
Moebius syndrome
public health
health
scientific knowledge production.
Abortion and misoprostol: health practices and scientific controversy
Resumo (abstract):
This article puts into perspective the controversy between the association between use of misoprostol for abortion and teratogenicity studies of the type found in a case report, and the consecration of the use of herbal medicinal drug in the medical-obstetric and national norms and international governing the registration and circulation of pharmaceuticals. Through the monographic method, were reviewed, systematized and analyzed official documents of ANVISA, Ministry of Health and World Health Organization on the use of misoprostol, as well as 68 articles such as case reports, published in national journals, linking abortion , misoprostol and teratogenicity. The legal prohibition of abortion prevents the proper prescription and use of a drug that produces effects safe and effective as misoprostol. Thus, the great harm to the health of women is linked not to the intrinsic characteristics of the drug, but the moral arguments that represent negligence and contempt for the fundamental rights of women.
Palavras-chave (keywords):
abortion
misoprostol
Moebius syndrome
public health
health
scientific knowledge production.
CORRÊA, Marilena C. D. V., Mastrella , M.. Aborto e misoprostol: usos médicos, práticas de saúde e controvérsia científica. Cien Saude Colet [periódico na internet] (2012/mar). [Citado em 23/12/2024].
Está disponível em: http://cienciaesaudecoletiva.com.br/artigos/aborto-e-misoprostol-usos-medicos-praticas-de-saude-e-controversia-cientifica/9586?id=9586
